Spire Healthcare Maintains Sale Talks
Spire Healthcare has confirmed that discussions for a potential sale of the business are still underway, even after private equity firms Bridgepoint and Triton stated they will not proceed with offers, according to a report by Private Equity Wire citing Reuters. The UK-listed private hospital operator launched a strategic review in September 2025 and revealed in January that it was engaging with multiple potential bidders, including Bridgepoint and Triton.
Reasons for Withdrawal
Bridgepoint explained that it could not finalize a deal structure satisfying all stakeholders, while Triton did not provide reasons for its decision to step back, as detailed in the same report. Spire has cautioned that there is no guarantee a transaction will occur or what terms might be involved if one does materialize.
Company Operations and Context
Spire operates 38 hospitals and more than 50 clinics, medical centres, and consulting rooms across the UK, with a current market capitalisation of around £765m according to LSEG data. Separately, Spire’s board and management are exploring alternative actions to enhance long-term shareholder value, such as those previously indicated in Sky News reports about Bridgepoint’s exploratory bid exceeding £1bn. As a widely-known aspect of private equity, such strategic reviews often involve assessing multiple options to maximize returns for investors.
Potential Next Steps
The company is continuing to engage with other parties regarding the sale, but emphasized the uncertainty of any outcome, according to Private Equity Wire. This development highlights the fluid nature of private equity transactions in the healthcare sector.
